Vista Exclusive Content
“Swimmingly” Vista Partners Weekly Market Update 7-14-18
Vista Partners has published “Swimmingly” Vista Partners Weekly Market Update 7-14-18 and is accessible on our Newsletters Page. Each issue is written by Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe that spans
Roche Completes Acquisition of Cancer Data Company Foundation Medicine
Swiss pharma giant, Roche, bought the rest of Foundation Medicine for $2.4 billion on Tuesday. Foundation Medicine is a company that collects genetic data from samples of cancer tissue or blood. Roche already held a majority stake in Foundation Medicine, making the deal value at
Merck’s KEYTRUDA Gains Additional Approval From FDA
Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some the of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue
Company News Around The Web
21 September 2018 | 2:43 pm
Galectin's GR-MD-02 Positive in Phase Ib Study...
Galectin Therapeutics (GALT) posts favorable results from a ...
21 September 2018 | 2:31 pm
New Indications Are Expected to Drive Future...
According to Goldman Sachs analyst Jami Rubin, Merck’s (MR...
21 September 2018 | 1:02 pm
Keytruda Is a Major Growth Asset for...
In the first half of the year, Keytruda accounted for 15.27%...
21 September 2018 | 11:32 am
Why Merck Stock Has Risen 28.2% Year-to-Date
Merck (MRK) stock has risen from $54.93 on January 2 to $70....
21 September 2018 | 4:00 am
How Do Drugs Compete Against Each Other?
Investors can keep an eye on these four factors to tell whic...
20 September 2018 | 11:52 pm
Flexible labs, co-working space: Big Pharma is...
At an industry event Thursday, representatives from both Mer...
|Day Low - High||-|
|Year Low - High||-|